coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    East & Central Brighton PCN, Brighton and Hove (LAD) · Health Inequalities Profile

    PCN U29677 · NHS Surrey and Sussex Integrated Care Board; NHS Sussex Integrated Care Board · 9 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    71,977

    Registered population

    69.7% aged 18–64

    15.3%

    Aged 65+

    ICB 21.9% · England 17.9%

    16.1%

    Ethnic minority (non-White)

    5.5% Asian · England 9.6%

    41.3%

    In IMD quintile 1

    ICB 9.2% · England 21.0%

    ~26,484

    Core20 residents (est.)

    Resident basis; registered basis ~31,703 · see page 3

    8,996

    Hypertension register

    +3.42% in 3 yrs · England +5.60%

    1,444

    SMI register

    31.2% of Brighton and Hove (LAD)'s

    1,813

    COPD register

    Reviews +2.94% in 3 yrs

    Forecast to 2030

    9,635

    Hypertension patients, 2030

    +639 on today

    67.8%

    QRISK ≥20% on statins, 2030

    +4.00pp over 3 yrs

    3.7%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    59.4%
    Asthma annual reviews trail England (65.7%).

    Across 5,331 asthma patients (7.4% prevalence), 59.4% had an annual review (England 65.7%), leaving about 2,200 unreviewed; three-year change was +0.1% (England +4.4%).

    64.0%
    SMI physical health checks lag behind England.

    Psychosis alcohol recording is 64.0% (England 81.8%, down 1.4 pp vs England +5.4 pp) and SMI blood pressure checks reach 74.8% (England 83.4%).

    +7.3%
    Lipid therapy and SMI BMI trends beat England.

    Three-year growth in lipid-lowering therapy for QRISK ≥ 20% (+7.3% vs England +6.2%) and SMI BMI recording (+6.1 pp vs +5.1 pp) exceeded England.

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    Working-age adults comprise 69.7% of registered patients alongside 11,044 older adults

    Of 71,977 registered patients, 69.7% are aged 18–64 (Brighton and Hove 71.4%, NHS Sussex ICB 60.5%, England 62.7%) and 15.3% are aged 65+ (11,044 patients; Brighton and Hove 14.0%, NHS Sussex ICB 21.9%, England 17.9%). Census usual-resident data records 83.9% White (Brighton and Hove 85.4%, NHS Sussex ICB 91.0%, England 81.1%) and 16.1% non-White ethnic groups, with Arch Healthcare's catchment reaching 15.6% Asian and 7.6% Black residents. Projected growth to 2030 is 0.3% under unverified ONS modelling (Brighton and Hove 0.7%, NHS Sussex ICB 2.1%, England 2.3%). Catchment areas include 15 care homes with 503 beds.

    Age profile

    0–1715.0%
    18–6469.7%
    65+15.3%

    65+: ICB 21.9%, England 17.9%

    Ethnicity

    White83.9%
    Asian5.5%
    Mixed5.0%
    Other3.0%
    Black2.6%

    Older people · falls rows are Brighton and Hove (LAD) local-authority (LA) data, not PCN

    MeasureLocalSouth EastEnglandPeriod
    Falls admissions, 65+, per 100,000 (Brighton and Hove LA)2,7022,0181,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)75.3%82.2%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)52.6%57.8%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Brighton and Hove LA)1,4859819552024/25
    Falls deaths, all ages, per 100,000 (Brighton and Hove LA)19.914.014.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 patients comprise 41.3% of the PCN, spanning 87.3 pp across member practices

    Core20 patients comprise 41.3% of registered patients, exceeding England (21.0%), Brighton and Hove (17.6%) and NHS Sussex ICB (9.2%). Across practices, shares span 87.3 pp, from 12.7% at Woodingdean Medical Centre to 100.0% at Arch Healthcare. The PCN rate (41.3%) and practice-weighted share (44.0%) differ by 2.75 pp. St. Peter's Medical Centre holds the largest Core20 volume with 8,247 estimated patients (45.4%). The board must balance specialised inclusion pathways at high-concentration practices with broad clinical outreach across large-volume lists.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Arch Healthcare100.0% · 1,408 patients
    Broadway69.2% · 1,582 patients
    Wellsbourne59.8% · 5,029 patients
    Regency59.7% · 3,009 patients
    Ardingly Court50.2% · 3,090 patients
    Pavilion49.7% · 5,063 patients
    St. Peter's45.4% · 8,247 patients
    Park Crescent27.2% · 3,174 patients
    Woodingdean12.7% · 1,101 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    1,444

    SMI register

    1.93% recorded prevalence

    511

    Learning disability register

    0.68% recorded prevalence

    15

    Care homes, 503 beds

    In the PCN catchment

    8.2%

    Provide unpaid care

    Brighton and Hove (LAD), Census 2021

    The PCN records 1,444 severe mental illness patients (1.9% vs Brighton and Hove 1.4%, NHS Sussex ICB 1.1%, England 1.0%), representing 31.2% of the borough register, and 511 learning disability patients (0.7% vs 0.6% across comparators). The SMI register is above the England rate, so physical-health checks for this group are the larger workload to protect.

    Severe mental illness: physical health checks

    Severe mental illness prevalence is 1.9% (England 1.0%), yet annual blood pressure checks reach 74.8% (England 83.4%) and psychosis alcohol recording is 64.0% (England 81.8%). Prioritising physical health recall across these 1,444 patients could close monitoring gaps.

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    8,996

    Hypertension register

    +3.42%

    Register growth, 3 yrs

    Brighton and Hove (LAD) +7.27% · England +5.60%

    +1.45pp

    BP control, under 80

    ≤140/90 · −0.42pp aged 80+

    +639

    More patients by 2030

    Forecast 9,635 (12.84%)

    Hypertension case-finding and control

    Hypertension prevalence is 12.0% (8,996 patients), above Brighton and Hove (10.5%) but below England (15.2%) and NHS Sussex ICB (16.3%), with unconfirmed matching observation bases. While 87.9% of hypertensive patients had a recent blood pressure reading (England 90.0%), treatment to target reaches 64.7%, trailing England (70.3%), Brighton and Hove (66.5%) and the ICB (69.1%). For patients aged under 80, control is 63.7% (England 67.8%), and for those aged 80 and over it is 77.0% (England 81.2%). Blood pressure control lags national benchmarks across age groups despite high monitoring rates, suggesting the PCN could prioritise systematic medication reviews and titration protocols.

    Lipids and statins

    Lipid therapy reaches 58.9% of patients with QRISK ≥ 20%, matching Brighton and Hove (58.9%) but trailing NHS Sussex ICB (60.0%) and England (63.6%), despite +7.3% three-year change (England +6.2%). Fewer at-risk patients are on lipid-lowering therapy than the England rate would imply, so a recall audit could be considered.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026114,780£2.20£2.42£1.86£252,516
    Cardiovascular (all), 2025147,985£2.61£3.32£3.33£386,241

    For lipid-regulating drugs in 2026, the PCN prescribed 114,780 items at £2.20 per item (Brighton and Hove £2.47, NHS Sussex ICB £2.42, England £1.86), spending £39,025 more than at England's unit cost. Higher unit costs than England for lipid-regulating drugs could reflect local formulary choices, which could be examined through clinical audit.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    +0.13%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    +0.98%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.4% (England 6.6%), covering 5,331 registered patients, alongside youth prescribing of 1,807 items per 1,000 aged 5-19 (England 1,488 rate). Annual reviews reach 59.4% (England 65.7%), leaving about 2,200 patients unreviewed, while second-hand smoke recording reaches 70.8% (England 78.8%). COPD prevalence is 2.4% (England 1.9%, 1,813 patients), with reviews at 70.2% (England 76.4%). Lagging review completion alongside elevated prescribing suggests routine review capacity may not be keeping pace with respiratory disease burden.

    Cancer register and children's immunisation

    Cancer prevalence is 3.1% (2,325 patients), below England (3.8%). In childhood immunisations, 6-in-1 coverage at 12 months reaches 92.2% (target 95.0%). By age 5, first-dose MMR reaches 94.6%, but second-dose MMR falls to 89.2% (a 5.4 pp drop) and the 4-in-1 booster reaches 85.8%, lagging the 95.0% standard by 9.2 pp. Pre-school booster attrition leaves older children under-protected, indicating a need for targeted recall before school entry.

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months92.2%

    England 91.0%

    6-in-1 complete primary course at 24 months90.4%

    England 92.2%

    MMR dose 1 at 24 months89.5%

    England 88.3%

    MMR dose 2 at age 589.2%

    England 82.8%

    4-in-1 pre-school booster at age 585.8%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    58.5%

    Sussex ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~1,360

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Sussex ICBEnglandNo usable stageStaged cancers
    Prostate56.6%53.2%19%1,668
    Breast86.1%85.4%23%1,400
    Bowel49.8%47.0%26%1,133
    Lung30.3%33.8%15%1,058
    Skin cancer95.3%87.8%17%698

    For NHS Sussex ICB in 2022, 58.5% of staged cancers across all cancer sites were diagnosed at stage 1 or 2 (4,799 of 8,209 known-stage cases), above England (55.3%) by 3.2 percentage points but 16.5 pp below the 75.0% national ambition. Known-stage cancers formed 64.3% of registered diagnoses (8,209 of 12,766). Reaching the 75.0% ambition across the ICB would require about 1,360 additional early-stage diagnoses. System staging does not reflect PCN performance, but East & Central Brighton PCN lags on screening: cervical screening coverage at ages 25-49 is 57.6% (England 66.8%) and breast screening at ages 53-70 is 62.0% (England 69.9%).

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    At University Hospitals Sussex NHS Foundation Trust, the 62-day referral to treatment standard trailed the 85.0% operational standard by 19.8 pp, while the 31-day combined treatment standard trailed the 96.0% standard by 19.2 pp, and the 28-day faster diagnosis standard was 1.0 pp below the 75.0% standard. Across NHS Surrey and Sussex Integrated Care Board, performance was 13.5 pp below the 85.0% 62-day standard and 5.6 pp below the 96.0% 31-day standard, but 4.3 pp above the 75.0% faster diagnosis standard. These secondary-care waits could reflect acute pathway bottlenecks that may prolong diagnostic and treatment intervals, unverified locally.

    Pathways within standard (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareSurrey and Sussex ICBEngland
    28-day faster diagnosis (75%)74.0184.2077.7479.2979.32
    31-day treatment (96%)76.7998.1996.2090.4592.50
    62-day referral to treatment (85%)65.2067.0469.9771.5171.16
    Diagnostic waits over 6 weeks (%)SussexEast Sussex HealthcareSurrey and Sussex HealthcareEngland
    MRI5.626.4827.5321.40
    CT8.570.4818.499.92
    Echocardiography0.3921.9443.7828.48
    Colonoscopy39.350.7415.1130.83
    Gastroscopy20.020.3121.0629.02
    All 15 DM01 tests12.955.2728.5023.14
    Community services activityBrighton and Hove residentsSurrey and Sussex ICB
    Care contacts23,615309,615
    Referrals5,59066,930
    Patients with a contact7,35085,660

    Community services (residents of Brighton and Hove), Jun 2026 (provisional). In June 2026 (provisional), adults aged 65 and over accounted for 60.7% of all community service contacts for Brighton and Hove residents (14,325 of 23,615 contacts). This reflects local authority resident activity rather than PCN-specific delivery, indicating high community service use among older borough residents that interfaces with primary care chronic disease pathways.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    Practice variation and patient experience

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Arch Healthcare88100.092.5%78.6%100.0%
    Ardingly Court13250.273.1%77.7%91.7%
    Pavilion Surgery13249.785.0%78.4%90.6%
    Broadway Surgery9769.269.1%68.4%85.3%
    Wellsbourne10959.859.9%72.6%83.1%
    Regency Surgery9359.779.4%72.4%80.4%
    St. Peter's9645.438.5%58.8%74.9%
    Woodingdean11112.736.4%65.5%71.7%
    Park Crescent11027.233.8%58.2%60.9%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNBrighton and Hove (LAD)AssetPCNBrighton and Hove (LAD)
    Care homes (catchment)15 (503 beds)n/aSchools (catchment)70n/a
    Children's centres614Places of worship49113
    Libraries513Homelessness support (VCS)0no data
    Primary schools (LA maintained)1235Primary academies47
    Special schools22

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Structured asthma review recall

    Asthma annual reviews reach 59.4% vs 65.7% in England (6.3 pp below; Brighton and Hove 60.1%, ICB 62.5%) across 5,331 registered patients, leaving 2,165 (about 2,200) unreviewed. For discussion, the PCN could introduce a single recall template, flexible review slots, and combined inhaler-prescribing reviews. Moderate effort to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 2

    SMI physical health check outreach

    Across 1,444 SMI patients (1.9% prevalence; 31.2% of borough register), BP checks reach 74.8% vs 83.4% in England (8.6 pp below) and alcohol recording is 64.0% vs 81.8% (17.8 pp below). Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Option 3

    Pharmacist-led CVD and diabetes titration

    Across 8,996 hypertension patients (12.0% prevalence), treatment to target is 64.7% vs 70.3% in England (5.6 pp below), QRISK >= 20% lipid therapy is 58.9% vs 63.6%, and non-frail diabetes HbA1c <= 58 mmol/mol is 52.6% vs 57.4%. Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Catchment care home alignment (p2)Count of Care Homes in PCN catchmentFit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework: revenue finance and contracting guidance 2026PCN
    Two-track Core20 outreach model (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Severe mental illness health recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension control protocol review (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster recall (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Cervical screening uptake campaign (p7)Women (25-49 yrs) with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)Fit for the Future: 10 Year Health Plan for England · Medium Term Planning Framework 2026PCN
    Option 1 · Structured asthma review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 2 · SMI physical health check outreach (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Option 3 · Pharmacist-led CVD and diabetes titration (p12)Hypertension register · Hypertension: QOF prevalence · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15